Bone Marrow Transplant Clinical Trial - Sellas Life Science Group SLSG18-301
Bone marrow transplant
Status:Open (Study open and enrolling)
CONDITION(S): Acute Myeloid Leukemia - TRIAL: Sellas Life Science Group SLSG18-301-GPS Compared With BAT in AML CR2/CR2p
To assess the safety and efficacy of galinpepimut-S compared with investigator's choice of best available therapy (BAT) on overall survival (OS) in subjects with acute myeloid leukemia (AML) who are in second complete remission 2 (CR2)/second complete remission with incomplete platelet recovery (CR2p).